Literature DB >> 9790949

Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells.

T Kuzumaki1, T Kobayashi, K Ishikawa.   

Abstract

Genistein, the principal isoflavonoid in soybeans, is reported to inhibit cell cycle progression, but the molecular basis for this event is unknown. Here we show that genistein inhibits DNA synthesis and suppresses cyclin E-associated cyclin-dependent kinase-2 (CDK2) activity when quiescent BALB/c 3T3 fibroblasts are stimulated with serum. In these cells, a CDK2 inhibitor, p21(Cip1/WAF1), is markedly increased by genistein, but another CDK2 inhibitor, p27(Kip1), is not increased. In exponentially growing BALB/c 3T3 cells, genistein inhibits proliferation of the cells in a dose-dependent manner. Flow cytometric analysis and measurement of DNA synthesis indicate that genistein blocks the G1 to S phase transition of these cells, which is concomitant with G2-M arrest. In mouse B16-F1 melanoma cells, genistein also blocks the transition of G1 to S phase without arresting at G2-M at low doses. In both cell lines, genistein suppresses cyclin E/CDK2 activity and induces p21(Cip1/WAF1) expression. These results suggest that genistein affects the restriction point control of the cell cycle by inducing p21(Cip1/WAF1) expression in mouse fibroblast and melanoma cells. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790949     DOI: 10.1006/bbrc.1998.9462

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.

Authors:  Sonam Sinha; Samriddhi Shukla; Sajid Khan; Trygve O Tollefsbol; Syed M Meeran
Journal:  Mol Cell Endocrinol       Date:  2015-02-25       Impact factor: 4.102

2.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

Authors:  X Chen; H Zhou; Y B Liu; J F Wang; H Li; C Y Ung; L Y Han; Z W Cao; Y Z Chen
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

Review 3.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.

Authors:  Subash C Gupta; Ji Hye Kim; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

Review 5.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

6.  Growth suppression of human transformed cells by treatment with bark extracts from a medicinal plant, Terminalia arjuna.

Authors:  A Nagpal; L S Meena; S Kaur; I S Grover; R Wadhwa; S C Kaul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-09       Impact factor: 2.416

7.  Genistein at maximal physiologic serum levels induces G0/G1 arrest in MCF-7 and HB4a cells, but not apoptosis.

Authors:  Marcela S Tsuboy; Juliana C Marcarini; Alecsandra O de Souza; Natália A de Paula; Daniel J Dorta; Mário S Mantovani; Lucia R Ribeiro
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

8.  Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.

Authors:  Jin-Rong Zhou; Lunyin Yu; Ying Zhong; Rena L Nassr; Adrian A Franke; Sandra M Gaston; George L Blackburn
Journal:  Prostate       Date:  2002-10-01       Impact factor: 4.104

9.  BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

Authors:  Shahana Majid; Altaf A Dar; Ardalan E Ahmad; Hiroshi Hirata; Kazumori Kawakami; Varahram Shahryari; Sharanjot Saini; Yuichiro Tanaka; Angela V Dahiya; Gaurav Khatri; Rajvir Dahiya
Journal:  Carcinogenesis       Date:  2009-02-12       Impact factor: 4.944

Review 10.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.